Comparison between Arete 22 IPO and Rednex Pharmaceuticals IPO.
Arete 22 IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Rednex Pharmaceuticals IPO is a SME Bookbuilding proposed to list at BSE SME.
| Arete 22 IPO | Rednex Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Horizon Management Pvt.Ltd. | Hem Securities Ltd. |
| Registrar | MAS Services Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | ||
| DRHP | DRHP  | DRHP |
| RHP | ||
| Final Prospectus | ||
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Arete 22 IPO is up to ₹0.00 Cr whereas the issue size of the Rednex Pharmaceuticals IPO is up to ₹0.00 Cr. The final issue price of Arete 22 IPO is and of Rednex Pharmaceuticals IPO is .
| Arete 22 IPO | Rednex Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 56,50,000 shares | 27,36,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 56,50,000 shares | 27,36,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Arete 22 IPO opens on , while Rednex Pharmaceuticals IPO opens on . The closing date of Arete 22 IPO and Rednex Pharmaceuticals IPO is , and , respectively.
Arete 22 IPO P/E ratio is , as compared to Rednex Pharmaceuticals IPO P/E ratio of .
| Arete 22 IPO | Rednex Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Arete 22 Ltd.'s revenue increased by 89% and profit after tax (PAT) rose by 473% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)Rednex Pharmaceuticals Ltd.'s revenue increased by 88% and profit after tax (PAT) rose by 120% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.40 | 100 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 86.12 | 58.10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 12.62 | 23.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.02 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹12.65 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 60.20 | 45.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Arete 22 IPO Retail Individual Investors (RII) are offered 0 shares while in Rednex Pharmaceuticals IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Arete 22 IPO and 0 shares in Rednex Pharmaceuticals IPO.
| Arete 22 IPO | Rednex Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Arete 22 IPO subscribed in total, whereas Rednex Pharmaceuticals IPO subscribed .
